Fact CheckerSign in

NCT06495229Active, not recruitingPhase 3

Study of CM310 in Adolescent Subjects With Atopic Dermatis

A Multicenter, Single Arm, Open Label Study to Evaluate the Safety and Efficacy of CM310 in Adolescent Patients With Atopic Dermatitis

Source: ClinicalTrials.gov · Last updated 2 Oct 2025

Brief summary (registry, in English)

This is a multi-center, single arm, open label phase 3 study to evaluate the safety and efficacy of CM310 in children patients with moderate-to-severe atopic dermatitis.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
180 (estimated)
First submitted
2 Jul 2024
Start date
2 Aug 2024
Primary completion date
30 Aug 2026
Lead sponsor
Keymed Biosciences Co.Ltd
NCT number
NCT06495229

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 180
  • From 2 Aug 2024 to the primary completion date, 30 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any major surgery planned during the research period.

Other

  • Subjects with potential fertility do not agree to adopt efficient contraceptive measures throughout the entire study period; Pregnant or breastfeeding women, or women planning to conceive or breastfeed during the study period.
  • With any circumstance that the subject is not suitable to participate in this study.

Who the study is looking for

  • Have the ability to understand the study and voluntarily sign a written informed consent form (ICF).
  • Subjects who must complete the evaluation of Week 18 of the main study.
  • With Atopic Dermatitis.

Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peking University People's Hospital
Coordinator of this site? Confirm its status
BeijingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.